ISRCTN02900734已完成不适用
Improving medication safety for patients with chronic renal impairment in general practice
German Federal Ministry of Education and Research (Bundesministerium Für Bildung und Forschung [BMBF]) (Germany)0 个研究点目标入组 400 人开始时间: 2007年5月30日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patient level:
- •1. Patients with established chronic renal impaiment grade III or higher (creatinine clearance below 50 ml/min)
- •2. Patients at risk of developing chronic renal impairment (70 years or older with hypertension = risk group)
- •Practice level:
- •1. Use of computer during consultation
- •2. Use of computer for prescribing medications
排除标准
- •Patient level:
- •1. Terminally ill patients
- •2. Patients with dialysis treatment
- •Practice level:
- •Routine use of an electronic support system for dose adaption in patients with chronic renal impairment.
研究者
相似试验
招募中
Unknown
Effect of Pharmaceutical Care on patients with Chronic PaiArthritis, RheumatoidC05.550.114.606FibromyalgiaRBR-8494rf7niversidade Federal de Sergipe
已完成
不适用
Reducing pain and disability in patients with chronic musculoskeletal pain with a stretch class - A randomised controlled trialSigns and Symptoms: PainSigns and SymptomsPainISRCTN22547605Department of Health171
已完成
不适用
The clinical trial for safety and efficacy of chronic hepatitis therapeutics agent, 3-oxygelmillpropionic acid polymer for pancreatic cancer (Phase 1)Resectable pancreatic cancerJPRN-UMIN000027441Osaka University10
已完成
不适用
Polypharmacy reduction in patients treated for chronic diseasesISRCTN42003273German Federal Ministry of Education and Research (BMBF) (Germany)1,626
进行中（未招募）
1 期
Optimization of treatment for patients with chronic hepatitis C infected with a particular virus type (HCV-genotype 2 or 3): 12 vs. 24 weeks of treatment extension for patients with slow response to therapyEUCTR2008-000706-36-DEHannover Medical School; Competence Network Viral Hepatitis (Hep-Net)150